Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Share-Based Compensation

v3.24.3
Stockholders' Equity and Share-Based Compensation
9 Months Ended
Sep. 28, 2024
Stockholders' Equity and Share-Based Compensation  
Stockholders' Equity and Share-Based Compensation

Note 3 – Stockholders’ Equity and Share-Based Compensation

Options and Restricted Stock Units

The Company had the following common stock option activity during the thirty-nine weeks ended September 28, 2024:

Granted options to purchase 100 common shares.
Exercise of 0 options to purchase common shares.
Forfeiture of 5 options to purchase common shares.
Expiration of 91 options to purchase common shares.

The following table summarizes the Company’s restricted stock unit ("RSU") activity for the thirty-nine weeks ended September 28, 2024, and details regarding the awards outstanding and exercisable as of September 28, 2024 (in thousands):

Weighted Average

Grant Date

Aggregate

    

Shares

    

    

Fair Value

    

Intrinsic Value

Vested and expected to vest as of December 30, 2023

3,609

 

Awarded

2,293

 

Vested

(1,054)

 

Forfeited

(88)

 

Awards outstanding, September 28, 2024

4,760

 

$

6.37

 

$

4,311

Vested and expected to vest as of September 28, 2024

4,760

 

$

6.37

 

$

4,311

During the thirty-nine weeks ended September 28, 2024, 1,054 RSUs that vested were time-based and 0 were performance-based.

For the thirteen and thirty-nine weeks ended September 28, 2024, we recorded compensation costs related to stock options and RSUs of $3,187 and $9,528, respectively. For the thirteen and thirty-nine weeks ended September 30, 2023, we recorded compensation costs related to stock options and RSUs of $1,640 and $8,747, respectively. As of September 28, 2024, there was unrecognized compensation expense related to stock options and RSUs of $15,387 that will be expensed through September 2028.